45 results on '"SAINT-REMY, JEAN-MARIE"'
Search Results
2. Retroviral Vectors Induce Epigenetic Chromatin Modifications and IL-10 Production in Transduced B Cells via Activation of Toll-like Receptor 2
3. Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage pool
4. Tolerability and pharmacokinetics of TB-402 in healthy male volunteers
5. Kinetics and thermodynamics of interaction of coagulation factor VIII with a pathogenic human antibody
6. Crystal Structures of Mite Allergens Der f 1 and Der p 1 Reveal Differences in Surface-Exposed Residues that May Influence Antibody Binding
7. Mimotopes identify conformational B-cell epitopes on the two major house dust mite allergens Der p 1 and Der p 2
8. Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major allergen
9. In vivo neutralization of a C2 domain–specific human anti–Factor VIII inhibitor by an anti-idiotypic antibody
10. CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A
11. Low Molecular Weight Peptides Restore the Procoagulant Activity of Factor VIII in the Presence of the Potent Inhibitor Antibody ESH8
12. Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model
13. Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factor
14. Structure of a factor VIII C2 domain–immunoglobulin G4κ Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII
15. Antigenicity of putative phospholipid membrane-binding residues in factor VIII
16. A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor
17. A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor
18. Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A
19. 62 - Coagulation factor autoantibodies
20. FVIII production by human lung microvascular endothelial cells
21. Chapter 45 - Clotting Disorders
22. Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor development
23. Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor
24. Phase I Clinical Trial of a Novel, Long-Acting Antithrombotic Drug: A Human Monoclonal Antibody Partially Inhibiting FVIII Activity.
25. VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors
26. Immune Tolerance Induction by High Doses FVIII in Hemophilia A Patients with Inhibitor Does Not Require Deletion of FVIII-Specific T Cells.
27. A Limited Number of Anti-Idiotypic Antibodies Is Required To Maintain FVIII Function in Presence of Polyclonal Anti-FVIII Antibodies of Haemophilia A Patients with Inhibitors.
28. The Determination of the Inhibitory Activity of Some Factor VIII Type II Inhibitor Antibodies Is Biased by the Type of Factor VIII Assay.
29. Rupture of T Cell Tolerance to Self Factor VIII in Mild/Moderate Hemophilia A.
30. Tolerance induction: a job for B cells?
31. Epitope mapping: a new method for biological evaluation and immunotoxicology
32. A novel therapy for atopic dermatitis with allergen-antibody complexes: A double-blind, placebo-controlled study
33. Identification of a specific epitope on the extracellular domain of the LDL-receptor of Trypanosoma brucei brucei
34. An Mr 145000 low-density lipoprotein (LDL)-binding protein is conserved throughout the Kinetoplastida order
35. Occupational asthma caused by sarsaparilla root dust
36. Seasonal variation in specific IgE antibodies of grass-pollen hypersensitive patients depends on the steady state IgE concentration and is not related to clinical symptoms
37. Latex allergosorbent test (LAST): A new immunoassay for specific IgE with latex particles
38. Anti-Factor VIII Antibodies of Hemophiliac Patients Are Frequently Directed Towards Nonfunctional Determinants and Do Not Exhibit Isotypic Restriction
39. Mechanism and Kinetics of Factor VIII Inactivation: Study With an IgG4 Monoclonal Antibody Derived From a Hemophilia A Patient With Inhibitor
40. [10] Idiotopes carried by antiallergen antibodies
41. Antigen-specific immunomodulation in vivo
42. Idiotypes and anti-idiotypes in allergy
43. Coagulation Factor VIII Autoantibodies
44. CHAPTER 65 - ACQUIRED INHIBITORS TO CLOTTING FACTORS
45. CONTRIBUTORS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.